LOGIN
Carbazochrome Sodium Sulfonate + Tranexamic Acid After Total Hip Arthroplasty
May 2024
Carbazochrome Sodium Sulfonate + Tranexamic Acid After Total Hip Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparative study of carbazochrome sodium sulfonate and tranexamic acid in reducing blood loss and inflammatory response following direct anterior total hip arthroplasty: a prospective randomized controlled trial.
Int Orthop . 2023 Oct;47(10):2553-2561.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients with osteoarthritis or femoral head necrosis were randomized to receive either a combination of tranexamic acid (TXA) and carbazochrome sodium sulfonate (CSS) (TXA + CSS; n=50) or TXA alone (n=50). The primary outcome of interest was total perioperative blood loss. Secondary outcomes of interest included hidden blood loss, intraoperative blood loss, postoperative blood transfu...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.